Urologic Oncology involves the diagnosis, comprehensive treatment, and follow-up of patients with cancers of the prostate, bladder, kidney, testicle, adrenal gland, penis and retroperitoneum. Numerous medical and surgical advances over the past several years have improved the treatments of these malignancies, with earlier diagnosis, fewer treatment-related complications and side effects, and most importantly, more cures and enhanced survival in many cases.
Patients undergoing surgery for prostate cancer need no longer assume nor expect impotence as a result of "cutting the nerves." Refinements in the technique of nerve sparing and "continence-sparing" radical prostatectomy can now deliver advanced cancer therapy, along with fewer side effects.
Patients with bladder cancer that require cystectomy (removal of the bladder) can now be offered several options for urinary reconstruction which have eliminated the need for a permanent urinary ostomy (ileal conduit). These new techniques help improve both self image and patient lifestyles dramatically.
Other Urologic Cancers
Similarly, numerous other advances and improvements have been developed for kidney cancer, testicular cancer, and other urologic malignancies. Methodical and precise follow-up and proper management of cancer-related complications are also an integral component of comprehensive Urologic Oncology care. Familiarity with all of these treatment modalities, and the development of new innovations in cancer care are the basis of Urologic Oncology.
For additional information or patient referrals, please call Dr. Nicholas Karanikolas, director of Urologic Oncology at (718) 226-6031. Our fax number is (718) 226-1599. You may also contact the Department of Urology via
this e-mail link.